Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
Alexandros Spyridonidis(General University Hospital of Patras), Mohamad Mohty(Sorbonne Université), Arnold Ganser(Medizinische Hochschule Hannover), Frédéric Baron(University of Liège), Jordi Esteve(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Dietrich W. Beelen(Essen University Hospital), Didier Blaise(Institut Paoli-Calmettes), Francesco Lanza(Ospedale "Santa Maria delle Croci" di Ravenna), Fabio Ciceri(Vita-Salute San Raffaele University), Jurjen Versluis(Erasmus MC), Ali Bazarbachi(American University of Beirut), Roni Shouval(Memorial Sloan Kettering Cancer Center), Nöel Milpied(Hôpital Cardiologique du Haut-Lévêque), Yngvar Fløisand(University of Oslo), Anne Huynh(Institut universitaire du cancer de Toulouse Oncopole), Jaime Sanz(Hospital Universitari i Politècnic La Fe), Myriam Labopin(Sorbonne Université), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Riitta Niittyvuopio, Florent Malard(Sorbonne Université), Christoph Schmid(University Hospital Augsburg), Norbert Claude Gorin(Sorbonne Université), Arnon Nagler(Sheba Medical Center), Zinaida Perić(University of Rijeka), Maria Gilleece(Leeds Teaching Hospitals NHS Trust), Jan J. Cornelissen(Erasmus MC), Laimonas Griškevičius(Vilnius University), Charles Craddock(University Hospitals Birmingham NHS Foundation Trust), Uwe Platzbecker(National Center for Tumor Diseases), Annalisa Ruggeri(Inserm), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Gesine Bug(Goethe University Frankfurt), Éolia Brissot(Inserm), Bipin N. Savani(Vanderbilt University Medical Center), Gèrard Socié(Hôpital Saint-Louis)
Cited by 202
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k